Future Study With Tolvaptan in Acute Heart Failure

被引：4

作者：

Goldsmith, Steven R. ^{[1
]}

机构：

[1] Hennepin Cty Med Ctr, Div Cardiol, 701 Pk Ave South,Orange 5, Minneapolis, MN 55415 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 04期

关键词：

D O I：

10.1016/j.jacc.2016.11.032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：467 / 467

页数：1

共 5 条

[1]

Felker GM, 2016, J AM COLL CARDIOL

[2]

Hauptman PJ, 2014, CIRC J, V78, P911

[3] Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure [J].

Jujo, Kentaro ;

Saito, Katsumi ;

Ishida, Issei ;

Furuki, Yuho ;

Kim, Ahsung ;

Suzuki, Yuki ;

Sekiguchi, Haruki ;

Yamaguchi, Junichi ;

Ogawa, Hiroshi ;

Hagiwara, Nobuhisa .

ESC HEART FAILURE, 2016, 3 (03) :177-188

[4] Immediate Administration of Tolvaptan Prevents the Exacerbation of Acute Kidney Injury and Improves the Mid-Term Prognosis of Patients With Severely Decompensated Acute Heart Failure [J].

Shirakabe, Akihiro ;

Hata, Noritake ;

Yamamoto, Masanori ;

Kobayashi, Nobuaki ;

Shinada, Takuro ;

Tomita, Kazunori ;

Tsurumi, Masafumi ;

Matsushita, Masato ;

Okazaki, Hirotake ;

Yamamoto, Yoshiya ;

Yokoyama, Shinya ;

Asai, Kuniya ;

Shimizu, Wataru .

CIRCULATION JOURNAL, 2014, 78 (04) :911-921

[5]

Starling RC, 2016, J AM COLL CARDIOL

← 1 →